AJO LP’s ANI Pharmaceuticals ANIP Stock Holding History

AJO LP’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,828	Closed	-$237K	–	685
2020 Q1	$237K	Buy	+5,828	New	+$310K	﹤0.01%	549

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AJO LP's ANIP Position: Q2 2020 in Review

AJO LP sold out of ANI Pharmaceuticals (ANIP) in Q2 2020, closing a stake of 5,828 shares — an estimated $237K sold.

AJO LP first reported a position in ANIP in Q1 2020 and held it in 1 quarter. The position peaked at $237K in Q1 2020. 134 funds tracked by Wall St. Rank hold ANIP as of Q2 2020.

AJO LP reported no remaining ANI Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
AJO LP sold 5,828 ANI Pharmaceuticals shares in Q2 2020, an estimated $237K.
AJO LP first reported a position in ANI Pharmaceuticals in Q1 2020 and held it in 1 quarter.
AJO LP's ANI Pharmaceuticals position peaked at $237K in Q1 2020.
134 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2020.

Based on AJO LP's 13F filing for Q2 2020, filed 12 Aug 2020.